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Coxsackievirus B3 induced murine myocarditis depends upon CD1d expression and upon a population of CD1d-restricted Vγ4+ T cells.
Infection upregulates CD1d expression in CD4+ T cells. Bone marrow chimeras were made between BALB/c and BALB/c CD1d−/− mice and
showed that CD1d expression in either hemopoietic and non-hemopoietic cells induces myocarditis, although CD1d expression on hemopoietic
cells was more effective in increasing Vγ4+ cell numbers and activation, and CD4+ IFNγ+ cell response than CD1d expression on non-
hemopoietic cells. Co-culture of enriched CD4+ cells from infected CD1d−/− and BALB/c mice with Vγ4+ T cells demonstrated that the Vγ4+
cells bias the CD4+ cell response to the Th1 phenotype through CD1d. Anti-CD1d antibody effectively blocked promotion of IFNγ expression by
the CD4+ cell population. These results show that Vγ4+ cells modulate developing adaptive immunity through recognition of CD1d on CD4+ T
cells, and that this interaction, more than Vγ4+ cell interaction with infected cardiocytes, determines pathogenicity.
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CD1 is a major histocompatibility complex class 1-like
molecule and consists of a single heavy polypeptide chain
associated with β2 microglobulin (Gadola et al., 2002; Porcelli,
1995; Stanic et al., 2003; Zeng et al., 1997). CD1 molecules
primarily present self glycolipids to T cells (Porcelli, 1995;
Zeng et al., 1997), although microbial lipid antigens may also be
presented (Skold and Behar, 2003). Some evidence suggests
that different types of cells do not contain the same sets of CD1-
restricted self lipid antigens since autoreactive T cell clones
respond to some but not all cells expressing the same CD1
molecule (Brossay et al., 1998; Park et al., 1998). There are two
groups of CD1 molecules. Group 1 consists of CD1a, b and c,
while group 2 consists of CD1d. Only the CD1d is expressed in
mice (Rhind, 2001). Hemopoietic derived cells, including
dendritic cells, macrophage and selected populations of B and T
lymphocytes, express CD1d (Exley et al., 2002; Kronenberg
and Gapin, 2002; Stanic et al., 2003). Non-hemopoietic cellsE-mail address: Sally.Huber@uvm.edu.
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doi:10.1016/j.virol.2006.04.014such as endothelial cells, cardiac myocytes, hepatocytes and
intestinal epithelial cells can be CD1d+, at least under certain
conditions such as virus infection (Exley et al., 2002; Huber et
al., 2003; Kronenberg and Gapin, 2002; Stanic et al., 2003).
CD1d-restricted T cells mediate innate immunity. The most
widely recognized CD1d-restricted cells are invariant natural
killer T cells (iNKT) (Behar et al., 1999; Bendelac et al., 1997;
Exley et al., 2002; Kronenberg and Gapin, 2002; Stanic et al.,
2003). We have shown that a population of γδ+ T cells
expressing the Vγ4 T cell receptor chain are also CD1d
restricted (Huber et al., 2003).
CD1-restricted T cells have multiple functions. They can
directly kill CD1+ targets through perforin- or Fas-dependent
mechanisms (Bendelac et al., 1995; Huber et al., 2003; Miyagi
et al., 2003), modulate the adaptive immune response
presumably through rapid secretion of Th1- or Th2-biasing
cytokines (Exley et al., 2002; Hameg et al., 1999; Johnson et al.,
2002; Lee et al., 2002) and upregulate other types of innate
response (Carnaud et al., 1999). CD1-restricted cells increase
dendritic cell maturation and dendritic cell induced activation of
CD8+ cytolytic T lymphocytes (Leslie et al., 2002; Stober et al.,
2003; Vincent et al., 2002). Dendritic cell maturation requires
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leading to improved antigen presentation to antigen-specific
CD4+ T cells. Depending upon the disease, CD1-restricted
immunity can have beneficial or detrimental effects in microbial
disease (Skold and Behar, 2003). CD1-restricted cells are
required for clearance of pseudomonas (Nieuwenhuis et al.,
2002) and may be beneficial in encephalomyocarditis virus
(EMC-D) infections (Exley et al., 2001). In contrast, the
presence of CD1-restricted cells increases inflammation and
pathogenicity in coxsackievirus B3 (Huber et al., 2003) and
respiratory syncytial virus (RSV) (Johnson et al., 2002)
infections. CD1-restricted cells seem to have minimal effects
in cytomegalovirus (van Dommelen et al., 2003) and lympho-
cytic choriomeningitis virus (Spence et al., 2001) infections.
In the murine model of coxsackievirus B3-induced myocar-
ditis, cardiac myocytes and endothelial cells upregulate CD1d
expression when infected with the highly pathogenic H3 variant
of the virus. CD1d-restricted Vγ4+ cells kill infected
cardiocytes through recognition of CD1d on these cells
(Huber et al., 2003). Uninfected cardiocytes are not killed
because these cells fail to upregulate CD1d (Huber and Sartini,
2005). The ability of Vγ4+ cells to kill infected cardiocytes
should help control virus infection but could also contribute to
pathogenicity, especially if substantial numbers of cardiocytes
are eliminated. Vγ4+ cells also promote virus-specific CD4+
Th1 (IFNγ+) responses, and this CD4+ Th1 response is
essential to induction of autoimmune (myocyte-specific) CD8+
effector cells (Huber et al., 2002b). This means that Vγ4+ cells
have two potential mechanisms for causing cardiac pathology:
the direct killing of infected myocytes; and the indirect role in
autoimmune CD8+ T cell response. This communication shows
that Vγ4+ cell modulation of CD4+ cell activation is the moreFig. 1. CD1d expression in PBMC. Peripheral blood mononuclear cells were isolate
infection with 104 PFU H3 virus and labeled with antibodies to CD4 and CD1d. Num
from BALB/c uninfected mice and PE-rat IgG2b and FITC-anti CD4. The table gives
(5 to 6 weeks of age). *Significantly different than uninfected group at P < 0.05.important effect in myocarditis and that this modulation
involves CD1d expressed on the CD4+ cells.
Results
CD1d expression in hemopoietic cells is required for cardiac
inflammation
Previous studies have shown that coxsackievirus B3
infection of cardiac myocytes upregulates expression of
CD1d and Vγ4+ cells kill infected cardiocytes through
CD1d recognition in vitro (Huber et al., 2002b, 2003). Vγ4+
cells also modulate developing virus-specific CD4+ cell
responses toward a Th1 (IFNγ+) phenotype, and this CD4+
Th1 response subsequently promotes activation of autoimmune
CD8+ effectors (Huber et al., 2002b). The following study
determined that CD1d expression on hemopoietic cells is also
increased during virus infection. BALB/c CD1d−/− and Balb/c
male mice were infected with H3 virus and killed 7 days later.
Peripheral blood mononuclear cells (PBMC) were isolated and
labeled with antibodies to CD1d and CD4 (Fig. 1). Controls
were PBMC from uninfected BALB/c mice and the isotype
control (uninfected BALB/c PBMC incubated with PE-rat
IgG2bk and FITC-anti CD4). Few CD4+ cells from uninfected
mice expressed CD1d (0.5%) although 6.4% of non-CD4+
cells were CD1d+. With virus infection, CD4+ CD1d+ cells
increased to 4.1%, and the non-CD4+ CD1d+ cells increased
to 32.0%. Infection not only increased the number of CD1d+
cells but also increased the mean fluorescence intensity (MFI)
of CD1d staining indicating increased antigen/cell. Little CD1d
expression was observed on PBMC from infected CD1d−/−
mice.d from uninfected BALB/c mice and CD1d−/− and BALB/c mice 7 days after
bers indicate the percent cells in each quadrant. The isotype control used PBMC
mean ± SEMmean fluorescence intensity for flow staining of 4–5 mice per group
Fig. 2. Analysis of reconstitution of bone marrow chimera mice. Recipient mice were given two doses of 600R then reconstituted with 5 × 107 bone marrow (BM) cells
i.v. Transgenic GFP-BALB/c mice were used since presence or absence of GFP would indicate efficiency of engraftment. PMBC were obtained from recipient mice 4
weeks after bone marrow transplantation and were labeled with antibody to CD3 (T cells). Top strain designation over each graph indicates bone marrow donor mouse
strain. Bottom strain designation over each graph indicates recipient mouse strain. Number indicates %CD3+GFP+ cells. Mice were 9 weeks of age when euthanized.
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hemopoietic or non-hemopoietic cells is most relevant to
cardiac inflammation. Bone marrow chimera mice were made
by i.v. injection of 5 × 107 bone marrow cells from donor mice
into irradiated recipients. CD1d−/− recipients received either
CD1d−/− or GFP-BALB/c bone marrow, while GFP-BALB/c
recipients received CD1d−/− bone marrow. Fig. 2 gives
representative flow diagrams showing the efficiency of bone
marrow transplantation by measuring GFP+ CD3+ cells in an
individual mouse for each group. A mean of 89 ± 7% (n = 4)
CD3+ cells from CD1d−/− mice given GFP-BALB/c bone
marrow were GFP+, while a mean of 8 ± 3% (n = 4) CD3+
cells from GFP-BALB/c recipients given CD1d−/− bone
marrow were GFP+ demonstrating that the predominant
CD3+ cell populations were of the bone marrow donor type.
CD1d−/− mice given homologous (CD1d−/−) bone marrow
developed minimal myocarditis and few CD4+ IFNγ+ cells
(Figs. 3–5). BALB/c mice transplanted with GFP-BALB/c
bone marrow developed severe myocarditis characterized by
both mononuclear cell inflammation and extensive myocyte
necrosis (Fig. 3). Animal mortality for the different groups was
CD1d−/− BM > CD1d−/−, 0/7 mice; CD1d−/− BM > GFP-
BALB/c, 2/7 mice; GFP-BALB/c BM > CD1d−/−, 6/11 mice
(P < 0.05 compared to CD1d−/− BM > CD1d−/− group); andGFP-BALB/c BM > GFP-BALB/c, 5/10 mice (P < 0.05
compared to CD1d−/− BM > CD1d−/− group). These mice
also show strong CD4+ Th1 responses to infection (Fig. 4 gives
the summary for all mice in each group, and Fig. 5 gives
representative flow diagrams for an individual animal per
group). CD1d−/− mice given GFP-BALB/c bone marrow also
developed significant myocardial inflammation similar to
BALB/c recipients given BALB/c bone marrow. CD4+
IFNγ+ T cell responses were also elevated in this group. In
contrast, GFP-BALB/c mice given CD1d−/− bone marrow
show much reduced myocardial inflammation, although
inflammation in this group is higher that in CD1d−/− mice
given CD1d bone marrow. CD4+ Th1 responses were
significantly less in recipients given CD1d−/− bone marrow
compared to recipients given GFP-BALB/c (CD1d+/+) bone
marrow.
Vγ4+ cell prevalence depends upon CD1d expression in
hemopoietic cells during H3 infection
The %Vγ4+ cells in the PBMC are shown in Fig. 6. Infected
CD1d−/− mice given CD1d−/− bone marrow have few Vγ4+
cells, while BALB/c mice given BALB/c mice have high levels
of these cells as has been shown previously (Huber et al.,
Fig. 3. Histology of bone marrow chimeric mice infected with H3 virus. Four weeks after bone marrow transplantation, recipient mice were infected with 104 PFU H3
virus. Mice were killed 7 days after infection. Hearts were formalin fixed, sectioned and stained with hematoxylin and eosin. Arrows indicate areas of inflammation.
First strain designation above each photomicrograph indicates the bone marrow (BM) donor strain, and second strain designation indicates bone marrow recipient.
Mice were 9 weeks of age when euthanized.
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develop high levels of Vγ4+ cells, while BALB/c mice given
CD1d−/− bone marrow do not. Thus, the hemopoietic cell
population in H3-infected mice is one factor determining the
prevalence of the Vγ4+ cell response.
Vγ4+ cells modulate IFNγ expression in CD4+ cells
Since virus infection augments CD1d expression on PBMC
and Vγ4+ cell response, and since previous studies implicate
Vγ4+ cells in induction of the CD4+ IFNγ bias, the following
studies evaluated whether Vγ4+ cells can directly affect CD4+
cell responses and whether this effect is mediated through CD1d
expression on the CD4+ cells. Enriched Vγ4+ cells (96.7%)
were isolated from the spleens of H3-infected BALB/c mice
(Fig. 7A). CD4+ T cells were isolated from the spleens of H3-
infected BALB/c and CD1d−/− mice (85.5% and 90.3%,
respectively, CD4+ cells; Fig. 7B gives a representative flow
diagram of CD4+ cell purity). CD4+ cells were cultured with or
without Vγ4+ cells for 72 h in the presence of u.v. inactivated
virus loaded and irradiated adherent splenocytes. Splenocytes
were isolated from either uninfected BALB/c (CD1d+/+) or
CD1d−/− donor mice. Fig. 7C shows cytokine expression of the
CD4+ cells after culture as determined by flow cytometry.
Fewer CD4+ IFNγ+ cells were detected when CD4+ cells came
from infected CD1d−/− mice than when these cells came from
CD1d+/+ donors. CD4+ T cells from infected BALB/c mice
showed significantly increased IFNγ response when cultured in
the presence of Vγ4+ cells compared to cultures without Vγ4+cells (15.3% with CD1d+/+ APC and 10.7% with CD1d−/−
APC compared to 6.5% and 6.2% for CD4+ cells cultured
without Vγ4+ cells on the respective APC populations). CD4+
cells from CD1d−/− mice failed to significantly increase IFNγ
expression when cultured with Vγ4+ cells. To confirm that Vγ4
+ cells modulate CD4+ T cell responses through recognition of
CD1d, monoclonal antibody to CD1d (100 μg/ml) was added to
the cultures of virus-immune BALB/c CD4+, Vγ4+ and virus-
loaded APC throughout the 3-day culture (Fig. 7C). Anti-CD1d
effectively prevented the enhanced CD4+ Th1 response. The
lack of strong IFNγ response by CD1d−/− CD4+ T cells does
not indicate that the cells are unresponsive to virus. Replicate
cultures were stimulated with virus, irradiated CD1d+/+ antigen
presenting cells (APC) and labeled with 3H-thymidine for the
last 12 h of culture. Both CD1d−/− and BALB/c CD4+ T cells
from virus infected donor mice showed strong proliferation to
virus (CD1d+/+ CD4+ cells: 9562 ± 367 cpm; CD1d−/− CD4+
cells: 6978 ± 559 cpm). As published previously (Huber et al.,
2003), coxsackievirus B3 infected CD1d−/− mice produce a
substantial CD4+IL-4+ cell response while lacking a strong
CD4+ IFNγ+ response. Presumably, the proliferating CD4+
cells in CD1d−/− mice represent CD4+ Th2 cells.
A final method to determine if the effects of Vγ4+ cells are
mediated directly on CD4+ cells through CD1d involved co-
culture of GFP-CD4+ T cells from infected GFP-BALB/c mice
and CD4+ CD1d−/− cells from infected BALB/c CD1d−/−
mice with or without Vγ4+ cells from infected BALB/c mice in
the presence of BALB/c (CD1d+/+) adherent cells loaded with
u.v. virus. Additional controls were CD1d−/− CD4+ cells or
Fig. 4. (A) Cardiac virus titers in bone marrow chimeric mice 7 days after infection. (B) Percent myocardium inflamed as determined by image analysis in mice 7 days
after infection. (C) PBMC from infected mice were stimulated for 4 h with PMA, ionomycin and brefeldin A, then labeled with antibody to CD4. The cells were fixed,
permeabilized and intracellularly labeled for IFNγ and IL-4. First strain designation is bone marrow (BM) donor strain type, and second strain designation is bone
marrow recipient strain. Results represent mean ± SEM of 8 to 14 mice per group. *Significantly different than GFP-BALB/c recipients given GFP-BALB/c bone
marrow (GFP-BALB/BMc > GFP-BALB/c) at P ≤ 0.05 (B; solid line). #Significantly different than CD1d−/− recipients given CD1d−/− bone marrow (CD1d−/−
BM > CD1d−/−BM) at P ≤ 0.05 (B; dashed line). ##GFP-BALB/c BM > CD1d−/− recipient group is significantly different than CD1d−/− BM/GFP-BALB/c
recipient group at P < 0.05 (B; arrowed line). Mice were 9 weeks of age when euthanized.
Fig. 5. Flow cytometry of PBMC labeled for cell surface CD4 and intracellular IFNγ. Numbers indicate the percent cells in each quadrant.
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Fig. 6. Vγ4+ cells in PBMC of bone marrow chimera mice. PBMCwere isolated
from uninfected CD1d−/− and GFP-BALB/c mice and the H3-infected bone
marrow chimera mice described in Fig. 4 and labeled with antibody to Vγ4 for
flow analysis. Results represent the mean ± SEM of PBMC labeling with anti-
Vγ4 from 8–14 mice per group. *Significantly different than GFP-BALB/c
mice receiving GFP-BALB/c BM at P < 0.01. #Significantly different than
CD1d−/− mice receiving CD1d−/− BM at P < 0.05. Mice were 9 weeks of age
when euthanized.
Fig. 7. Purity of Vγ4+ (A) and CD4+ (B) cell populations used in cell culture assays.
H3 virus were depleted of B cells and monocytes, labeled with antibody to Vγ4 and C
96.7%. Enriched CD4+ cells were isolated from infected BALB/c splenocytes using
cell population was labeled with antibodies to CD4 and Vγ4 for flow cytometry ana
cultured for 3 days with irradiated antigen presenting cells [APC; irradiated adheren
with ultraviolet irradiated H3 virus. Left panel: CD4+ cells were from infected BALB
To half of the cultures, 104 purified Vγ4+ cells from spleens of infected BALB/c mice
additional wells containing virus-immune BALB/c CD4+ cells, virus-loaded APC a
lymphocytes were isolated, labeled with anti-CD4, fixed, permeabilized and labeled i
per group. *Significantly different than CD4+ cells not cultured with Vγ4+ cells at
231S.A. Huber / Virology 352 (2006) 226–236GFP-CD4+ cells separately cultured with Vγ4+ cells and
adherent cells loaded with virus. To one culture, 100 μg/ml
monoclonal anti-CD1d antibody was added at initiation of the
culture. Following culture, the cells were labeled with antibody
to CD4 and intracellularly labeled for IFNγ. Gating on the CD4+
cell population, the cells were analyzed for GFP+ and IFNγ+
(Fig. 8). Total CD4+ cells recovered were 0.38 ± 0.15 × 106 cells
for CD1d−/− CD4+ cultures, 0.63 ± 0.10 cells for GFP-CD4+
cultures, 0.55 ± 0.18 for CD1d−/− CD4+ and GFP-CD4+
without Vγ4+ cells, and 0.62 ± 0.20 for CD1d−/− CD4+ and
GFP-CD4+ cells cultured with Vγ4+ cells (5 replicates each).
Few IFNγ+ cells were observed with CD1d−/− CD4+ cells
cultured alone with Vγ4+ cells (0.4% of total CD4+ cells).
Significantly more IFNγ+ cells were observed with GFP-CD4+
cells cultured with Vγ4+ cells (2.9% of total CD4+ cells). Co-
culture of CD1d−/− and GFP-CD4+ cells without Vγ4+ cells
resulted in lower numbers of IFNγ+ cells than in either GFP-
CD4+ cells cultured with Vγ4+ cells or {CD1d−/− CD4+ and
GFP-CD4+} cells cultured with Vγ4+ cells. In the population
of {CD1d−/− CD4+ and GFP-CD4+} cells cultured with Vγ4+Splenocytes from 7-week-old BALB/c mice infected 7 days earlier with 104 PFU
D3 and sorted for the double positive (CD3+ Vγ4+) cell population. Purity was
the BD Biosciences CD4+ cell enrichment kit. An aliquot of the enriched CD4+
lysis. Purity of the CD4+ cells was 85.5%. (C) Enriched CD4+ T cells were co-
t splenocytes from either BALB/c CD1d+/+ or BALB/c CD1d−/− mice] loaded
/c (CD1d+/+) mice. Right panel: CD4+ cells were from infected CD1d −/−mice.
were added at initiation of culture. Antibody to CD1d (100 μg/ml) was added to
nd Vγ4+ cells. Brefeldin A was added during the last 4 h of culture, then the
ntracellularly for IFNγ. Results represent the mean ± SEM of 4 replicate cultures
P < 0.05.
Fig. 8. CD4+ cells were isolated from spleens of either 7-week-old CD1d−/− or GFP-BALB/c (CD1d+/+) mice infected 7 days earlier with 104 PFU H3 virus, then 1.0 × 106 CD4+ cells were cultured on irradiated, virus-
loaded BALB/c splenocytes (APC) with or without 1 × 104 purified Vγ4+ cells from H3-infected BALB/c donor mice. CD1d−/− and GFP-CD4+ cells were either cultured separately or co-cultured (0.5 × 106/cell type at
initiation of the culture). One culture of {CD1d−/− and GFP-BALB/c CD4+ T cells} and Vγ4 cells also had 100 μg/ml anti-CD1d added to the culture. The cells were cultured for 3 days and labeled intracellularly for
IFNγ and for CD4. Flow analysis gated on the CD4+ population and gives the percent of total CD4+ cells which are GFP+ and IFNγ+. Numbers in upper right hand corner indicates the percent of total CD4+ cells in each
quadrant.
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233S.A. Huber / Virology 352 (2006) 226–236cells, few CD1d−/− IFNγ+ cells were observed indicating that
CD1d−/− CD4+ cells are not indirectly activated to produce
cytokine by the presence of GFP-CD4+ cells and Vγ4+ cells.
Discussion
Bone marrow transplant studies show that CD1d expression
in the hemopoietic cell population is necessary for the CD4+
Th1 cell response during coxsackievirus B3 infections in mice
and results in substantial cardiac inflammation despite the
absence of CD1d in the heart. BALB/c mice transplanted with
CD1d−/− bone marrow lacked a strong CD4+ Th1 response but
developed more myocardial injury than CD1d−/− mice given
CD1d−/− bone marrow. These mice also had increased Vγ4+ T
cells compared to CD1d−/−mice given CD1d−/− bone marrow.
Since the BALB/c recipients would express CD1d in the
infected heart, the modest Vγ4+ cell activation in mice given
CD1d−/− bone marrow and the cardiac injury in these animals
most likely reflects the ability of CD1d+ non-hemopoietic cells
to activate Vγ4+ cells and for the activated Vγ4+ cells to
directly kill infected cardiocytes in the absence of a CD4+ Th1
cell response (Huber et al., 2003). Nonetheless, it is clear that
CD1d expression in hemopoietic cells is the dominant pathway
for immunopathogenicity. T cells and macrophage dominate in
the cardiac inflammatory cell infiltrate (Huber, 1997) and H3
infection is highly effective in upregulating CD1d expression in
both cell populations.
We have previously shown that TNFα is crucial for CD1d
upregulation (Huber and Sartini, 2005), and the H3 coxsack-
ievirus B3 variant is a potent inducer of this cytokine in
monocytes (Knowlton et al., 1996). Other investigators have
shown the seminal role of TNFα and IL-1β in myocarditis
(Eriksson et al., 2003; Kubota et al., 2000, 2001; Kumar et al.,
1996; Lane et al., 1992, 1993; Meldrum, 1998). TNFα has
multiple pathogenic effects including direct disruption of
myocyte contractility and modulation of immunopathogenic
responses. At least part of the effect of TNFα in viral myocarditis
may be its effects on CD1d expression. CD1d expression on
CD4+ T cells is important in Vγ4+ T cell modulation of the
cytokine response toward IFNγ expression. Previous studies
have shown that γδ+ T cells and specifically the Vγ4+
population are crucial to myocarditis susceptibility by promoting
CD4+ Th1 (IFNγ) responses in vivo (Huber, 1999, 2000; Huber
et al., 2000, 2001, 2002a, 2002b, 2003). The significance of the
CD4+ Th1 response is that it allows generation of autoimmune
CD8+ cytolytic T lymphocytes which are a major pathogenic
element in myocarditis (Huber, 1997; Huber and Lodge, 1984;
Huber et al., 2002b). Both IFNγ production and FasL expression
by Vγ4+ T cells is required to modulate CD4+ T cell cytokine
responses in vivo (Huber et al., 2001, 2002a). Vγ4+ cells are
CD1d-restricted and absence of CD1d in vivo both prevents Vγ4
+ cell activation and promotes CD4+ Th2 (IL-4+) responses at
the expense of CD4+ Th1 responses (Huber et al., 2003). The
question which was not addressed in previous publications is
whether CD1d is only required for Vγ4+ cell activation or
whether it is also directly involved in Vγ4+ cell modulation of
the CD4+ response. Studies have shown that Vδ1+ human cells,which recognize CD1c, were capable of promoting maturation
of dendritic cells and increased CD4+ T cell responses (Leslie et
al., 2002). Here, we show that the Vγ4+ cells involved in viral
myocarditis also directly affect adaptive immunity through
recognition of CD1d on hemopoietic cells. Activated Vγ4+ T
cells from infected BALB/c donor mice were capable of
enhancing CD4+ Th1 cell responses on CD1d+ virus-immune
BALB/c CD4+ cells but were ineffective with virus immune
CD4+ cells lacking CD1d. Also, addition of anti-CD1d
antibodies to the culture effectively blocked CD4+ Th1
activation. One possibility is that Vγ4+ cell modulation of
CD4+ cell responses occurs indirectly through the antigen-
presenting cell which would also be CD1d+. Use of CD1d−/−
antigen presenting cells slightly reduced Vγ4+ cell augmenta-
tion of the CD1d+/+ CD4+ cell response, but there is still a
strong CD4+ IFNγ+ response with these antigen presenting
cells. Thus, it seems likely that the major effect of the Vγ4+ cells
is mediated directly on the CD4+ T cell population.
An important question is why Vγ4+ T cells kill infected non-
hemopoietic cells, such as myocytes and endothelial cells
(Huber et al., 2003) but do not kill CD4+ T cells by CD1d. We
have previously shown that γδ+ T cells from CVB3 infected
mice can selectively kill CVB3-specific Th2 cell clones using
Fas-dependent mechanisms (Huber et al., 2002a). Virus-specific
Th1 cell clones are resistant to γδ+ T cell killing. This was a
highly unexpected observation in light of published studies that
CD4+ Th1 cells are much more susceptible to activation
induced cell death (Zhang et al., 1997), and that IFNγ has anti-
proliferative and pro-apoptotic effects on many cell types
(Inagaki et al., 2002; O'Connor et al., 2005). IFNγ upregulates
mRNA levels of both TNFR1 and caspase 8 (Inagaki et al.,
2002) which promote apoptosis, but simultaneously stimulate
the same cells to produce chemokines. Thus, IFNγ has both
negative and positive effects on the same cells. Since both the
CD4+ Th1 and Vγ4+ cells are IFNγ+ (Huber et al., 2001), one
would expect that the Th1 cells would be more strongly
signaled toward IFNγ-induced apoptosis than CD4+ Th2 cells
would be. The most likely explanation is that CD1d signaling
on the CD4+ Th1 cell activates anti-apoptotic pathways which
negate the pro-apoptotic effects of IFNγ. Although the
hypothesis is that Vγ4+ cells promote IFNγ expression, an
alternative explanation could be that the percent of CD4+ Th1
cells increases because CD4+ Th2 cells are eliminated. This
does not seem likely since few CD4+ Th2 cells are observed in
infected cell populations, and elimination of these few cells
should not account for the substantial increase in CD4+ Th1
cells.
Materials and methods
Mice
Male BALB/cJ mice, 4–9 weeks of age, were purchased
from Jackson Laboratories, Bar Harbor, ME. Breeding pairs of
BALB/c CD1d−/− mice were originally supplied by Dr. M.
Grusby (Harvard School of Public Health, Boston, MA) and
are currently maintained at the University of Vermont (Huber
234 S.A. Huber / Virology 352 (2006) 226–236et al., 2003). GFP-BALB/c breeding pairs were originally
obtained from Dr. Susan Swain (Trudeau Institute, Saranac
Lake, NY) and are currently maintained at the University of
Vermont.
Virus and virus titers
Animals were infected i.p. with 104 PFU virus as described
previously (Huber et al., 2003). Virus titers on homogenized
heart tissue were determined using the plaque-forming assay on
HeLa cells as described earlier (Knowlton et al., 1996).
Antibodies
Antibodies were purchased from BD Bioscience-Pharmin-
gen (San Diego CA). Antibodies used in these studies include
anti-CD3 (clone 17A2); anti-Vγ4 (clone UC3); anti-CD4 (clone
GK1.5); anti-CD1d (clone 1B1); anti-IFNγ (clone XMG1.2);
anti-IL-4 (clone BVD4-1D11); anti-CD16/CD32 (Fc Block;
clone 2.4G2); and rat IgG isotype controls (clones R3−5; clone
A95-1 and R3-34).
Lymphocyte isolation
Lymphocytes were isolated from peripheral blood and spleen
as described previously (Huber et al., 2000). Peripheral blood
was obtained by cardiac puncture into EDTA treated syringes
and placed into EDTA treated tubes. Splenocytes were isolated
by pressing spleens through fine mesh screens. Cell suspensions
were underlain with Histopaque-1077 (Sigma Chemical Co, St.
Louis, MO) and centrifuged at 1048×g for 15 min. Cells at the
interface were removed and washed in medium. CD4+ cells
were enriched from the splenocyte population using the BD
Biosciences CD4+ cell enrichment kit according to manufac-
turer's directions. Purified Vγ4+ cells were isolated as
described previously (Huber et al., 2000). Briefly, B cells and
monocytes were depleted from the splenocytes by incubation
with biotinylated anti-CD19 and anti-CD11b followed by
incubation with magnetic particles conjugated with anti-rat
IgG (BioMag; Polysciences, Warrington PA) and a magnet.
Next, the remaining cells were labeled with antibody to Vγ4
and CD3 then sorted using a BD FACS Aria flow cytometer
(San Jose, CA).
Bone marrow transplantation
Four-week-old mice were give two 600 R doses of
irradiation using a cesium irradiator 4 h apart. Bone marrow
donor mice were euthanized and the tibia and femur bones were
removed. Bone marrow was flushed from the bones, treated
with anti-CD3 antibody (1:50 dilution) and 20% rabbit
complement (Sigma) for 40 min at 37 °C, counted by trypan
blue exclusion and injected (5 × 107 cells/0.2 ml PBS) i.v.
through the tail vein of irradiated recipients within 6 h of the last
irradiation. Four weeks after bone marrow injection, animals
were either infected or euthanized to evaluate GFP labeling of
peripheral blood mononuclear cells.Flow cytometry
Details for intracellular cytokine staining have been
published previously (Huber et al., 2001). Briefly, 106
lymphocytes were cultured for 4 h in RPMI 1640 medium
containing 5% fetal bovine serum, 10 μg/ml of brefeldin A
(BFA), 50 ng/ml phorbol myristate acetate (PMA) and 500 ng/
ml ionomycin (Sigma). After culture, the cells were washed in
PBS–1% bovine serum albumin (BSA; Sigma) containing BFA,
incubated with 1:100 Cy-Chrome anti-CD4 in PBS-BSA-
brefeldin A for 30 min on ice, washed, fixed in 2%
paraformaldehyde for 10 min, then resuspended in PBS-BSA
containing 0.5% saponin, Fc Block and 1:100 dilutions of biotin
anti-IFNγ, streptavidin APC-Cy7 and PE-anti-IL-4 or biotin-
and PE-rat IgG1 (clone R3-34) and incubated for 30 min on ice.
The cells were washed once in PBS-BSA-saponin and once in
PBS-BSA, then resuspended in 2% paraformaldehyde and
analyzed using a BD FACS Aria flow cytometer with a single
excitation wavelength (488 nm) and band filters for Cy-chrome
(670 nm), and PE (575 nm). APC-Cy7 was analyzed using an
excitation wavelength (595 nm) and a band filter of 650 nm.
The cell population was classified for cell size (forward scatter)
and complexity (side scatter). At least 10,000 cells were
evaluated. Positive staining was determined relative to isotype
controls.
Cell surface staining
Cells were resuspended in 100 μl PBS-BSA containing
1:100 dilutions of Fc Block and fluorochrome labeled
antibodies to cell surface proteins. The cells were incubated at
4 °C for 30 min, washed twice with PBS-BSA and resuspended
in 2% paraformaldehyde for flow analysis. GFP was analyzed
on the flow cytometer using an excitation wavelength of 488 nm
and a band filter of 525 nm.
In vitro culture of CD4+ cells with Vγ4+ cells
Splenocytes were obtained from uninfected male BALB/c
and CD1d−/− mice and centrifuged on Histopaque as described
above. The cells were resuspended in RPMI 1640 medium with
10% FBS, antibiotics and L-glutamine and incubated for 90 min
at 37 °C in 60-mm2 plastic tissue culture dishes in a humidified
5% CO2 incubator at 5 × 10
6 cells/ml. The non-adherent cells
were removed by washing vigorously 4 times with 10 ml
medium each time. The remaining adherent cells were
incubated with 100 μg/ml monoclonal anti-CD3 antibody and
20% rabbit complement at 37 °C for 40 min. The cell monolayer
was washed three times, irradiated with 3000R, washed again,
and 1 ml fresh medium containing 107 PFU ultraviolet
irradiated H3 virus was added. The adherent cells were
incubated for 2 h and washed. Enriched CD4+ T cells
(1.0 × 106 cells) in 5 ml RPMI 1640-10% FBS were added.
To some cultures, 1.0 × 104 enriched Vγ4+ cells were added
with the CD4+ population. The cells were cultured for 3 days at
37 °C in a humidified CO2 incubator. Brefeldin Awas added to
the cultures 4 h before harvest. The lymphocytes were retrieved,
235S.A. Huber / Virology 352 (2006) 226–236labeled with antibody to CD4 and evaluated by intracellular
cytokine staining for IFNγ and IL-4 expression as described
above. In some cultures, 100 μg/ml monoclonal anti-CD1d was
added at the initiation of the culture. Additional wells were
labeled with 1 μCi 3H-thymidine for 12 h prior to harvest of the
lymphocytes onto glass fiber filters using a Bellco Microsample
Harvester. The filters were washed with excess water to remove
unincorporated radioactivity and then counted in a Packard
Liquid Scintillation counter.
Histology
The apical half of the heart was fixed in 10% buffered
formalin, sectioned, stained with hematoxylin and eosin, and
evaluated for myocarditis by image analysis as described
previously (Knowlton et al., 1996).
Statistical analysis
Statistical analysis was done by Wilcoxon Ranked Score.
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